| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft Rejection | 39 | 2024 | 4426 | 2.780 |
Why?
|
| Vascular Endothelial Growth Factor A | 25 | 2016 | 3484 | 1.710 |
Why?
|
| Heart Transplantation | 16 | 2018 | 3224 | 1.500 |
Why?
|
| Skin Transplantation | 7 | 2018 | 1083 | 0.970 |
Why?
|
| Endothelium, Vascular | 19 | 2010 | 4434 | 0.970 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2021 | 4353 | 0.920 |
Why?
|
| Kidney Transplantation | 17 | 2024 | 4214 | 0.850 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2022 | 2058 | 0.800 |
Why?
|
| Endothelial Cells | 10 | 2021 | 3539 | 0.770 |
Why?
|
| Transplantation, Homologous | 20 | 2018 | 4815 | 0.740 |
Why?
|
| Receptors, CXCR3 | 8 | 2012 | 238 | 0.730 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2013 | 544 | 0.650 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2016 | 663 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 2448 | 0.600 |
Why?
|
| Transplantation | 1 | 2019 | 218 | 0.600 |
Why?
|
| Neovascularization, Pathologic | 9 | 2015 | 2640 | 0.570 |
Why?
|
| Signal Transduction | 23 | 2019 | 23374 | 0.540 |
Why?
|
| CD40 Ligand | 10 | 2008 | 521 | 0.540 |
Why?
|
| Receptors, Chemokine | 5 | 2007 | 655 | 0.530 |
Why?
|
| Interferon-gamma | 6 | 2011 | 3157 | 0.520 |
Why?
|
| Chemokines, CXC | 4 | 2006 | 421 | 0.520 |
Why?
|
| Forkhead Transcription Factors | 4 | 2018 | 1613 | 0.510 |
Why?
|
| T-Lymphocytes | 15 | 2021 | 10181 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 3 | 2012 | 1336 | 0.480 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 730 | 0.470 |
Why?
|
| Transcriptional Activation | 4 | 2012 | 1754 | 0.470 |
Why?
|
| Sirolimus | 9 | 2022 | 1547 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2022 | 2873 | 0.460 |
Why?
|
| Cells, Cultured | 20 | 2021 | 18955 | 0.450 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 562 | 0.440 |
Why?
|
| Immunosuppressive Agents | 10 | 2015 | 4167 | 0.430 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2018 | 3075 | 0.420 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2013 | 278 | 0.420 |
Why?
|
| Cell Adhesion Molecules | 6 | 2013 | 1602 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2013 | 127 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 4356 | 0.400 |
Why?
|
| Multiprotein Complexes | 4 | 2015 | 1120 | 0.400 |
Why?
|
| Organ Transplantation | 4 | 2022 | 1150 | 0.400 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2012 | 62 | 0.390 |
Why?
|
| Cell Movement | 9 | 2018 | 5206 | 0.380 |
Why?
|
| Kidney Glomerulus | 3 | 2012 | 568 | 0.370 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2012 | 1810 | 0.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 2896 | 0.370 |
Why?
|
| Lymphokines | 3 | 2003 | 927 | 0.370 |
Why?
|
| Protein Kinases | 2 | 2008 | 1612 | 0.370 |
Why?
|
| Microvessels | 1 | 2015 | 572 | 0.360 |
Why?
|
| Cell Proliferation | 7 | 2019 | 10442 | 0.360 |
Why?
|
| Chemokine CXCL10 | 7 | 2015 | 316 | 0.350 |
Why?
|
| Mice, SCID | 8 | 2016 | 2627 | 0.350 |
Why?
|
| Graft Survival | 9 | 2024 | 3795 | 0.310 |
Why?
|
| Postoperative Complications | 5 | 2016 | 15679 | 0.310 |
Why?
|
| Inflammation | 8 | 2013 | 10755 | 0.300 |
Why?
|
| Chemokines | 6 | 2013 | 962 | 0.300 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2299 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 6216 | 0.290 |
Why?
|
| Hypertension, Renovascular | 1 | 2007 | 117 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 642 | 0.280 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2825 | 0.280 |
Why?
|
| Animals | 45 | 2022 | 167960 | 0.280 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 2007 | 0.280 |
Why?
|
| Lymphocyte Activation | 7 | 2015 | 5496 | 0.270 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3332 | 0.270 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 673 | 0.270 |
Why?
|
| Mitochondria | 1 | 2019 | 3601 | 0.270 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2007 | 213 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2802 | 0.260 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2634 | 0.260 |
Why?
|
| Cyclosporine | 5 | 2019 | 777 | 0.250 |
Why?
|
| Monocytes | 5 | 2003 | 2575 | 0.250 |
Why?
|
| Transplantation Tolerance | 2 | 2018 | 605 | 0.250 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 605 | 0.240 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2000 | 691 | 0.240 |
Why?
|
| Mice | 30 | 2022 | 81209 | 0.240 |
Why?
|
| Kidney | 4 | 2015 | 7064 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2018 | 2864 | 0.230 |
Why?
|
| Cell Communication | 5 | 2013 | 1653 | 0.230 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1181 | 0.230 |
Why?
|
| Sesquiterpenes | 1 | 2004 | 176 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 506 | 0.220 |
Why?
|
| Coronary Disease | 2 | 2016 | 5991 | 0.220 |
Why?
|
| Erythropoietin | 1 | 2007 | 720 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 5 | 2012 | 5782 | 0.210 |
Why?
|
| Immunologic Memory | 1 | 2009 | 1354 | 0.210 |
Why?
|
| Peritoneal Dialysis | 1 | 2004 | 157 | 0.210 |
Why?
|
| Isoantigens | 3 | 2001 | 552 | 0.210 |
Why?
|
| Leukocytes | 6 | 2006 | 2027 | 0.210 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 11902 | 0.200 |
Why?
|
| Heart | 1 | 2015 | 4393 | 0.200 |
Why?
|
| Intercellular Adhesion Molecule-1 | 6 | 1995 | 1126 | 0.200 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 46 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 22020 | 0.190 |
Why?
|
| CHO Cells | 2 | 2019 | 1389 | 0.190 |
Why?
|
| Humans | 85 | 2024 | 760613 | 0.190 |
Why?
|
| Histocompatibility Antigens | 2 | 2002 | 467 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 2471 | 0.180 |
Why?
|
| Cricetinae | 2 | 2019 | 2427 | 0.180 |
Why?
|
| Membrane Glycoproteins | 4 | 1999 | 3709 | 0.180 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 822 | 0.170 |
Why?
|
| Fibroadenoma | 1 | 2000 | 41 | 0.170 |
Why?
|
| Endothelium | 4 | 1999 | 764 | 0.170 |
Why?
|
| Mycophenolic Acid | 1 | 2002 | 343 | 0.170 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2000 | 103 | 0.170 |
Why?
|
| Telepathology | 1 | 2000 | 77 | 0.170 |
Why?
|
| CpG Islands | 1 | 2004 | 1221 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1652 | 0.160 |
Why?
|
| Flow Cytometry | 4 | 2016 | 5869 | 0.160 |
Why?
|
| RNA, Messenger | 10 | 2015 | 12762 | 0.160 |
Why?
|
| Simvastatin | 1 | 2021 | 352 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6465 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2009 | 558 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 728 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2018 | 8311 | 0.150 |
Why?
|
| Complement C5a | 2 | 2018 | 100 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2016 | 5039 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2007 | 1305 | 0.150 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2018 | 806 | 0.150 |
Why?
|
| Cricetulus | 1 | 2019 | 815 | 0.150 |
Why?
|
| Apoptosis | 7 | 2022 | 9497 | 0.150 |
Why?
|
| Tacrolimus | 2 | 2019 | 733 | 0.150 |
Why?
|
| Mice, Inbred C3H | 1 | 2018 | 915 | 0.140 |
Why?
|
| Interleukin-8 | 3 | 2018 | 698 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 748 | 0.140 |
Why?
|
| Transplantation Immunology | 1 | 1999 | 532 | 0.140 |
Why?
|
| Hyperplasia | 1 | 2000 | 1155 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2005 | 2982 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 3 | 2004 | 2470 | 0.130 |
Why?
|
| Myocardium | 4 | 2013 | 4700 | 0.130 |
Why?
|
| Umbilical Veins | 4 | 2006 | 426 | 0.130 |
Why?
|
| Jurkat Cells | 2 | 2009 | 736 | 0.130 |
Why?
|
| Methylation | 1 | 2018 | 1081 | 0.130 |
Why?
|
| Neuropilin-2 | 1 | 2015 | 55 | 0.130 |
Why?
|
| L-Selectin | 2 | 2011 | 209 | 0.130 |
Why?
|
| Primary Graft Dysfunction | 1 | 2016 | 111 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2093 | 0.120 |
Why?
|
| Cadherins | 1 | 2019 | 898 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2015 | 9288 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 1630 | 0.120 |
Why?
|
| Ammonia | 1 | 2015 | 236 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 2049 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2004 | 1801 | 0.120 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2007 | 382 | 0.120 |
Why?
|
| Isoantibodies | 1 | 2018 | 661 | 0.120 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 454 | 0.110 |
Why?
|
| Microfluidics | 2 | 2018 | 652 | 0.110 |
Why?
|
| Time Factors | 7 | 2015 | 40139 | 0.110 |
Why?
|
| Kidney Neoplasms | 3 | 2022 | 4312 | 0.110 |
Why?
|
| Luciferases | 2 | 2013 | 716 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14374 | 0.110 |
Why?
|
| Biopsy | 6 | 2024 | 6771 | 0.110 |
Why?
|
| Child | 17 | 2024 | 79799 | 0.110 |
Why?
|
| E-Selectin | 5 | 2006 | 576 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2015 | 203 | 0.110 |
Why?
|
| Child, Preschool | 12 | 2018 | 42056 | 0.110 |
Why?
|
| Chemokine CXCL11 | 1 | 2012 | 43 | 0.110 |
Why?
|
| P-Selectin | 1 | 1995 | 599 | 0.110 |
Why?
|
| Antigens | 2 | 2015 | 1447 | 0.110 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2015 | 261 | 0.100 |
Why?
|
| Interleukin-12 | 3 | 2001 | 584 | 0.100 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 3442 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2018 | 1368 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 116 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 11848 | 0.100 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 333 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 474 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 667 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2008 | 12102 | 0.100 |
Why?
|
| Protein Binding | 4 | 2015 | 9335 | 0.100 |
Why?
|
| Benzodioxoles | 1 | 2012 | 75 | 0.100 |
Why?
|
| Receptors, CCR4 | 1 | 2011 | 77 | 0.090 |
Why?
|
| Glomerulonephritis | 1 | 1993 | 337 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15286 | 0.090 |
Why?
|
| Calcineurin | 2 | 2009 | 229 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 1881 | 0.090 |
Why?
|
| Chemotaxis | 2 | 2014 | 598 | 0.090 |
Why?
|
| Tissue Donors | 2 | 2018 | 2314 | 0.090 |
Why?
|
| Foreskin | 1 | 2010 | 31 | 0.090 |
Why?
|
| Models, Immunological | 2 | 2003 | 513 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 3 | 2007 | 364 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1995 | 1096 | 0.090 |
Why?
|
| Transplants | 1 | 2012 | 206 | 0.090 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 571 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4571 | 0.090 |
Why?
|
| Male | 21 | 2019 | 359718 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2012 | 535 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 7593 | 0.080 |
Why?
|
| Lung | 1 | 2007 | 9994 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2015 | 18137 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 1992 | 1130 | 0.080 |
Why?
|
| Reperfusion Injury | 2 | 2006 | 1023 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3568 | 0.080 |
Why?
|
| Microcirculation | 2 | 2007 | 1278 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7850 | 0.080 |
Why?
|
| Podocytes | 1 | 2012 | 402 | 0.080 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2007 | 58 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 728 | 0.070 |
Why?
|
| Polyradiculoneuropathy | 1 | 1987 | 65 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 2379 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9530 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1617 | 0.070 |
Why?
|
| Stem Cells | 2 | 2013 | 3524 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2924 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4193 | 0.070 |
Why?
|
| Models, Biological | 5 | 2015 | 9468 | 0.070 |
Why?
|
| Neutrophils | 2 | 2018 | 3767 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2001 | 967 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4350 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2018 | 221 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2001 | 1342 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6659 | 0.060 |
Why?
|
| Adolescent | 11 | 2018 | 87809 | 0.060 |
Why?
|
| Biological Transport | 1 | 2010 | 2086 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 16548 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 1992 | 2209 | 0.060 |
Why?
|
| Quinazolines | 1 | 2012 | 1363 | 0.060 |
Why?
|
| Liver Circulation | 1 | 2005 | 159 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2008 | 1091 | 0.060 |
Why?
|
| Nephritis | 1 | 2006 | 149 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1999 | 1446 | 0.060 |
Why?
|
| Cytokines | 6 | 2006 | 7344 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2004 | 174 | 0.060 |
Why?
|
| Regeneration | 1 | 2013 | 1506 | 0.060 |
Why?
|
| Infant | 8 | 2018 | 36053 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2532 | 0.060 |
Why?
|
| Cyclohexanes | 1 | 2004 | 152 | 0.060 |
Why?
|
| ras Proteins | 1 | 2009 | 1051 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 3276 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4263 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2007 | 1954 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3844 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 295 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 361 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 825 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5659 | 0.060 |
Why?
|
| Heart Diseases | 2 | 2015 | 2809 | 0.060 |
Why?
|
| Graft vs Host Reaction | 1 | 2003 | 103 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4550 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2009 | 3607 | 0.050 |
Why?
|
| Biological Availability | 1 | 2004 | 395 | 0.050 |
Why?
|
| Gene Expression | 2 | 2011 | 7587 | 0.050 |
Why?
|
| Mammals | 1 | 2008 | 1131 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 6498 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2003 | 119 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2651 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2004 | 1154 | 0.050 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2004 | 187 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 2104 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1697 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4408 | 0.050 |
Why?
|
| Drug Costs | 1 | 2010 | 1185 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2421 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 16932 | 0.050 |
Why?
|
| Research Design | 1 | 2018 | 6180 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12531 | 0.050 |
Why?
|
| Trachea | 1 | 2007 | 1082 | 0.050 |
Why?
|
| Lignans | 1 | 2022 | 84 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 1997 | 1705 | 0.050 |
Why?
|
| Ischemia | 2 | 2007 | 1893 | 0.050 |
Why?
|
| RNA Interference | 1 | 2010 | 2846 | 0.050 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2001 | 27 | 0.050 |
Why?
|
| Homeostasis | 1 | 2012 | 3306 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 3280 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 713 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 217 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2005 | 11070 | 0.050 |
Why?
|
| Female | 16 | 2018 | 391246 | 0.050 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2001 | 516 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 562 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2018 | 26179 | 0.040 |
Why?
|
| Acute Disease | 4 | 2005 | 7268 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2440 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 296 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1668 | 0.040 |
Why?
|
| Adult | 9 | 2015 | 220007 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 2180 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1148 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2007 | 3663 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3787 | 0.040 |
Why?
|
| Risk Factors | 5 | 2018 | 74333 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 242 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1088 | 0.040 |
Why?
|
| Living Donors | 2 | 2000 | 636 | 0.040 |
Why?
|
| Skin | 3 | 2000 | 4466 | 0.040 |
Why?
|
| Creatinine | 1 | 2024 | 1904 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2165 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2006 | 1728 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1130 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2008 | 4089 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 1999 | 181 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2018 | 54306 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2005 | 2486 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2004 | 1063 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 2018 | 196 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2006 | 21029 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2006 | 1302 | 0.040 |
Why?
|
| Haplorhini | 1 | 1998 | 529 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2022 | 992 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3448 | 0.040 |
Why?
|
| Orbital Diseases | 1 | 1999 | 178 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2002 | 638 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 1553 | 0.040 |
Why?
|
| Macrophages | 3 | 2006 | 5745 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4899 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2002 | 1254 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2001 | 963 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2018 | 717 | 0.030 |
Why?
|
| Headache | 1 | 2004 | 1249 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2004 | 4035 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2001 | 756 | 0.030 |
Why?
|
| Antigens, CD | 2 | 1999 | 4000 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1249 | 0.030 |
Why?
|
| Abscess | 1 | 1999 | 605 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4938 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2001 | 1039 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2015 | 64981 | 0.030 |
Why?
|
| Middle Aged | 7 | 2015 | 220359 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 8512 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 215 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 820 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22052 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2000 | 653 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 708 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1996 | 445 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 2014 | 0.030 |
Why?
|
| Rats | 4 | 2006 | 23709 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3612 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2725 | 0.030 |
Why?
|
| Neoplasms | 4 | 2018 | 22075 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1337 | 0.030 |
Why?
|
| Transfection | 3 | 2007 | 5781 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1895 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 302 | 0.030 |
Why?
|
| Observer Variation | 1 | 2000 | 2601 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6029 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 9185 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2141 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 280 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 1246 | 0.030 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1992 | 65 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1992 | 40 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 4319 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 1827 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 14494 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 780 | 0.030 |
Why?
|
| Immunity | 1 | 2018 | 998 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11890 | 0.020 |
Why?
|
| Prognosis | 3 | 2018 | 29661 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39262 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 321 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3142 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 282 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2003 | 25941 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 15620 | 0.020 |
Why?
|
| Papio | 1 | 1992 | 661 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1992 | 449 | 0.020 |
Why?
|
| Diastole | 1 | 1993 | 788 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7408 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10185 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 58748 | 0.020 |
Why?
|
| Sinusitis | 1 | 1999 | 990 | 0.020 |
Why?
|
| Age Factors | 2 | 2004 | 18413 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12427 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 4924 | 0.020 |
Why?
|
| raf Kinases | 1 | 2009 | 118 | 0.020 |
Why?
|
| Liver | 1 | 2005 | 7510 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1895 | 0.020 |
Why?
|
| Ion Channels | 1 | 1994 | 1043 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 384 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6316 | 0.020 |
Why?
|
| Urochordata | 1 | 1988 | 19 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 899 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 1204 | 0.020 |
Why?
|
| Cadaver | 1 | 1992 | 1345 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2325 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1501 | 0.020 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2010 | 345 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 2049 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1994 | 1166 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2007 | 108 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1992 | 1818 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9591 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1993 | 3094 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2009 | 475 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2006 | 203 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1796 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2005 | 47 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 13505 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 6377 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3047 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 4925 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1601 | 0.020 |
Why?
|
| Collagen | 1 | 1993 | 2636 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 613 | 0.020 |
Why?
|
| Rabbits | 2 | 2006 | 4773 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4563 | 0.010 |
Why?
|
| Ultrasonography | 2 | 1999 | 5961 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1995 | 2164 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2004 | 93 | 0.010 |
Why?
|
| Genes, ras | 1 | 2006 | 654 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1995 | 3486 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2002 | 24102 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1992 | 1869 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 768 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2829 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1199 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1763 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2913 | 0.010 |
Why?
|
| Edema | 1 | 2006 | 770 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12810 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4902 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2536 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20080 | 0.010 |
Why?
|
| Hybridomas | 1 | 1982 | 442 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2007 | 80345 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1173 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1032 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1982 | 859 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9406 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8055 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8652 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1408 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2006 | 936 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2006 | 1096 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4463 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4673 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3734 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 2138 | 0.010 |
Why?
|
| Wound Healing | 1 | 2008 | 2788 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11481 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2723 | 0.010 |
Why?
|
| Recurrence | 1 | 1987 | 8483 | 0.010 |
Why?
|
| Bufonidae | 1 | 1994 | 12 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 58980 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3465 | 0.010 |
Why?
|
| Dermatitis | 1 | 1996 | 200 | 0.010 |
Why?
|
| Informed Consent | 1 | 2000 | 1005 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 317 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 4542 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1993 | 98 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1993 | 169 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1994 | 2186 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 1744 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 6359 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1992 | 384 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2001 | 1915 | 0.010 |
Why?
|
| Cause of Death | 1 | 2001 | 3725 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2418 | 0.010 |
Why?
|
| Appendicitis | 1 | 1996 | 674 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5795 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 1605 | 0.000 |
Why?
|
| Health Status | 1 | 2000 | 4082 | 0.000 |
Why?
|
| Prednisone | 1 | 1992 | 1566 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 169143 | 0.000 |
Why?
|
| Mental Health | 1 | 2000 | 3213 | 0.000 |
Why?
|
| Comorbidity | 1 | 2001 | 10553 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1994 | 3682 | 0.000 |
Why?
|
| Registries | 1 | 2000 | 8458 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12968 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2394 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7475 | 0.000 |
Why?
|
| Secretory Rate | 1 | 1982 | 81 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 4742 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8158 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12444 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1996 | 3763 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17624 | 0.000 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1982 | 545 | 0.000 |
Why?
|
| Genes | 1 | 1982 | 1845 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20509 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1982 | 4626 | 0.000 |
Why?
|